IC-MedTech Licenses Promising Cancer Therapeutic From Summa Health System
Dual Small Molecule Approach Demonstrates Ability to Induce a Wide Range of Cancer Cells to Self-Destruct in Animal Models
30-Aug-2004 -
Indian Creek Medical
Technologies, LLC announced it has exclusively licensed a novel
anti-cancer therapeutic that, in animal studies, causes a wide variety of
cancer cells to self destruct. Developed by Summa scientists, together with
research teams from several universities and hospitals in the ...
cell lines
clinical trials
cyclophosphamide
+5